Skip to main content

Table 3 England (1999 to 2011): rate ratios for respiratory and non-respiratory tuberculosis (TB) for people with immune-mediated diseases

From: Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies

Immune-mediated disease Respiratory TB rate ratio, (95% CI) Non-respiratory TB rate ratio, (95% CI)
Addison's disease 6.5 (4.4 to 9.4) 33.0 (25.1 to 42.6)
Ankylosing spondylitis 4.6 (3.4 to 6.0) 4.7 (2.8 to 7.3)
Autoimmune hemolytic anemia 7.2 (4.6 to 10.7) 4.3 (1.4 to 10.1)
Chronic active hepatitis 3.0 (1.0 to 7.0) 9.3 (3.7 to 19.3)
Crohn's disease 3.3 (2.8 to 3.9) 5.7 (4.6 to 6.9)
Coeliac disease 2.8 (2.2 to 3.7) 1.6 (0.9 to 2.7)
Dermatomyositis 9.6 (4.2 to 19.0) 5.3 (0.6 to 19.2)
Polymyositis 8.7 (4.8 to 14.7) 8.7 (3.2 to 18.9)
Goodpasture's syndrome 11.3 (3.1 to 29.0) 15.0 (1.8 to 54.4)
Hashimoto's thyroiditis 2.9 (1.2 to 6.0) 1.8 (0.2 to 6.5)
Idiopathic thrombocytopenia purpura 3.8 (2.7 to 5.1) 5.3 (3.4 to 8.0)
Multiple sclerosis 1.0 (0.6 to 1.4) 0.8 (0.4 to 1.5)
Myasthenia gravis 3.1 (1.9 to 5.0) 2.5 (0.8 to 5.9)
Myxedema 1.6 (1.5 to 1.8) 2.0 (1.7 to 2.2)
Pemphigus 1.1 (0.0 to 6.2) 6.2 (0.8 to 22.3)
Pemphigoid 2.3 (1.2 to 4.1) 3.1 (1.0 to 7.3)
Pernicious anemia 2.2 (1.6 to 2.8) 2.4 (1.4 to 3.7)
Polyarteritis nodosa 8.6 (3.7 to 16.9) 3.0 (0.1 to 16.9)
Primary biliary cirrhosis 4.0 (2.1 to 6.8) 7.9 (4.1 to 13.8)
Psoriasis 2.9 (2.4 to 3.5) 2.5 (1.8 to 3.4)
Rheumatoid arthritis 3.6 (3.2 to 3.9) 3.2 (2.7 to 3.8)
Scleroderma 6.2 (4.0 to 9.1) 3.8 (1.5 to 7.8)
Sjögren's syndrome 4.8 (3.2 to 6.9) 4.8 (2.5 to 8.2)
Systemic lupus erythematosus 8.4 (6.6 to 10.5) 14.6 (11.3 to 18.7)
Thyrotoxicosis 2.3 (1.9 to 2.8) 2.4 (1.7 to 3.2)
Ulcerative colitis 1.7 (1.4 to 2.0) 1.8 (1.4 to 2.4)